© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Regulation

Top Section/Ad

Top Section/Ad

Most recent


Reforms should focus on banks' access to liquidity, not capital
FIG
Conditions support capital issuance, even though European Commission's report gave no clarity on the future of AT1s
IPO pipeline strong, but timetables slipping as markets await clarity on tax, growth and defence funding
State-owned bank Spuerkeess has not indicated when it will issue its first bond
More articles/Ad

More articles/Ad

More articles

  • The multi-billion dollar Indian participatory note market is at risk following a regulatory proposal that threatens to nix tax treaties that have allowed noteholders and issuers hedging those instruments to avoid capital gains tax.
  • There’s speculation that Rep. Collin Peterson (D-Minn.), chairman of the House Agriculture Committee, could be considering his own over-the-counter derivatives bill, independently from Barney Frank (D-Mass.), chairman of the House Financial Services Committee.
  • European regulators are warning against adopting the same over-the-counter regulatory proposals being put forward in the U.S.
  • A new over-the-counter derivatives bill put forward by Sen. Jack Reed (D-RI) would give the Securities and Exchange Commission oversight of all security-based derivatives, including those referencing broad-based indices—indices with 10 or more component securities.
  • More end-users have started lobbying the U.S. Congress to change parts of the proposed over-the-counter derivatives bill, and a high-ranking Congressman last Tuesday said he believes dealers have been pressuring them to act.
  • The Obama administration’s proposed over-the-counter derivatives reforms have got some hedge funds pondering the future of synthetic prime brokerage under a mandate that could see standardized OTCs centrally cleared and traded on exchange.